Artrya Limited Stock Analysis: Rapid Growth and AI Potential
Artrya Limited (ASX:AYA) has been making waves in the Australian healthcare technology sector with its innovative AI-driven solutions for coronary artery disease detection. As of December 30, 2025, AYA.AX trades at A$4.71, reflecting a robust 678% increase over the past year. Let’s delve into the factors that have contributed to this remarkable performance and what the future holds for Artrya.
Company Overview and AI Initiatives
Artrya Limited operates at the intersection of healthcare and artificial intelligence. Founded in 2018 and headquartered in West Perth, Australia, the company offers Salix, a cloud-based AI software that assists in diagnosing coronary artery disease using coronary computed tomography angiography. This…
